We also found that the general OS and DFS of patients with ABCC3 overexpression in all kinds of glioma were significantly lower than those of patients with low expression of ABCC3 which indicated that high expression of ABCC3 may act as a poor molecular marker for glioma patients prognosis. This evidence concerns the gene ABCC3 and central nervous system cancer.